• Will Illumina pull off its $7.1B bid to acquire Grail? EU regulators may have final say

    2 days ago - By San Diego Biotechnology

    The European Commission has until Nov. 29 to decide whether the acquisition of cancer diagnostic firm Grail would stifle competition. Illumina says blocking the deal will cost lives
    Read more ...

     

  • Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase

    2 days ago - By San Diego Biotechnology

    SAN DIEGO--Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase.
    Read more ...